Abstract 3025: Optimization of therapeutic index of SGR-3515, a first-in-class Wee1/Myt1 inhibitor through intermittent dosing for monotherapy and combination with chemotherapy in xenograft tumor models
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Shaoxian Sun, Felicia Gray, Sarah Silvergleid, Robert Pelletier, Lin Tang, Andrew Placzek, Jiashi Wang, Pieter Bos, Jennifer Knight, Anthony Clark, Zhijian Liu, Naveen Thakral, Aleksey Gerasyuto
Institution: Schrodinger (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409629764